#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema Anti-glomerular basement membrane disease SAPHO syndrome Cerebral arteriovenous malformation haemorrhagic Porphyria non-acute Acute graft versus host disease in liver Orthostatic hypotension Candida infection Oesophageal squamous cell carcinoma stage III Urea cycle disorder Facioscapulohumeral muscular dystrophy Oesophageal atresia Factor IX deficiency Pemphigoid Bronchiolitis More trials…

    Learn about Rare Diseases

    CADASIL – Treatment Systemic mastocytosis – Basic Information Familial amyotrophic lateral sclerosis Prader-Willi syndrome – Diagnostics CADASIL Undifferentiated sarcoma – Life with Disease Haemophilia – Diagnostics Soft tissue sarcoma – Diagnostics Pleomorphic leiomyosarcoma Hereditary optic atrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Infliximab Colchicine Munc-Cd34 PIROXICAM Df6002 Cdr132L Grwd5769 Abt-494 Tebentafusp Teropavimab OBI-821 Emibetuzumab Catequentinib Dihydrochloride Isoflurane Pimecrolimus Davutamig Bi 764532 Dextrose Bp IPN01195 RO7837195 More therapies…

    Learn about Your Condition

    Angiosarcoma metastatic Colon cancer stage III Vitiligo Colorectal adenoma Vasospasm Generalised anxiety disorder Oesophageal disorder Brain neoplasm Neuropathic arthropathy Postoperative wound infection Anorexia nervosa Nephropathy Ehlers-Danlos syndrome Fallopian tube cancer Small intestine carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium France Germany Italy The Netherlands Poland +1

  • Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular thyroid cancer
    • Thyroid cancer
    • Papillary thyroid cancer
    Investigated Drugs:
    • Sodium Iodide (131I)
    France

  • Study on Ropivacaine Hydrochloride for Reducing Pain After Hip Surgery in Patients Undergoing Periacetabular Osteotomy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteotomy
    • Procedural pain
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Saline
    Denmark

  • Study on the Safety and Effectiveness of Fluocinolone Acetonide Implant for Children Aged 6-17 with Recurrent Non-Infectious Uveitis in the Eye’s Posterior Segment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chorioretinitis
    Investigated Drugs:
    • Fluocinolone Acetonide
    Germany Spain

  • Study of RMC-6236 and Pembrolizumab with or without Chemotherapy for Patients with RAS-Mutated Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    • Cisplatin
    • Pemetrexed
    France Germany Italy The Netherlands Spain

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Niraparib
    • Niraparib Tosilate Monohydrate
    • Bevacizumab
    Belgium France Italy Spain
Previous Page
1 … 510 511 512 513 514 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!